Clinical Trials Logo

Clinical Trial Summary

This is a phase I safety and immunogenicity trial comparing high-dose (HD)trivalent inactivated influenza vaccine (TIV) to standard dose (SD) TIV in pediatric patients with Acute Lymphoblastic Leukemia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01216332
Study type Interventional
Source Vanderbilt University Medical Center
Contact
Status Completed
Phase Phase 1
Start date October 2010
Completion date May 2013